| Authors: |
Koishikawa T; Laboratory of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences, the University of Tokyo, Bunkyo-ku, Tokyo, Japan., Tomoda Y; Laboratory of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences, the University of Tokyo, Bunkyo-ku, Tokyo, Japan., Tsuchitani T; Faculty of Pharmacy, Keio University, Minato-ku, Tokyo, Japan., Taskar K; Drug Metabolism and Pharmacokinetic, GSK, Stevenage, United Kingdom., Yoshida K; Clinical Pharmacology, Genentech, Inc., South San Francisco, California., Mao J; Drug Metabolism and Pharmacokinetics, Genentech, Inc., South San Francisco, California., Takashima T; Laboratory for Safety Assessment & ADME, Pharmaceuticals Research Center, Asahi Kasei Pharma Corporation, Shizuoka, Japan., Lai Y; Drug Metabolism Department, Gilead Sciences Inc, Foster City, California., Sugiyama Y; Laboratory of Quantitative System Pharmacokinetics/Pharmacodynamics, Innovation Base, Josai International University, Tokyo, Japan., Kusuhara H; Laboratory of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences, the University of Tokyo, Bunkyo-ku, Tokyo, Japan. Electronic address: kusuhara@mol.f.u-tokyo.ac.jp. |
